Midatech news
Web1 jun. 2024 · -- Midatech Pharma a déclaré mercredi que la Food and Drug Administration américaine a accordé la désignation fast track au programme de développement du MTX110, un traitement potentiel pour ... Web19 jun. 2024 · Commission File Number 001-37652. Midatech Pharma PLC. (Translation of registrant's name into English) Oddfellows House, 19 Newport Road, Cardiff, CF24 0AA, United Kingdom (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20 …
Midatech news
Did you know?
Web7 apr. 2024 · This Prospectus Supplement is being filed in order to incorporate into and include in the Prospectus the information set forth in our Form 6-K filed with the Securities and Exchange Commission on April 6, 2024, which is attached hereto. This Prospectus Supplement should be read in conjunction with the Prospectus and is qualified by … Web28 mrt. 2024 · Dr. Dmitry Zamoryakhin, Chief Science Officer of Midatech, said the following about the news: “We are very excited about accelerating this promising programme …
Web27 mrt. 2024 · ABINGDON, OXFORDSHIRE / ACCESSWIRE / March 27, 2024 / Midatech Pharma PLC (AIM:MTPH.L) (Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution ... Web14 nov. 2024 · Midatech Pharma PLC (dual listed on LSE AIM: MTPH; and NASDAQ: MTP) is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines.
Web27 mrt. 2024 · Midatech Pharma plc (AIM:MTPH) entered into a definitive agreement to acquire Bioasis Technologies Inc. (TSXV:BTI) from The Lind Partners, LLC and others for $5.5 million. Dec 15 + 1 more update Midatech Pharma plc announced that it expects to receive $10 million in funding Dec 14 Web27 mrt. 2024 · Midatech Pharma PLC (dual listed on LSE AIM:MTPH; and NASDAQ:MTP) is a drug delivery technology company focused on improving the bio-delivery and bio …
Web17 jun. 2024 · ABINGDON, OXFORDSHIRE/ ACCESSWIRE / June 17, 2024 / Midatech Pharma PLC (AIM:MTPH.L) (NASDAQ:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodistribution of medicines, announces breakthrough in vitro data which demonstrate Q-Sphera's potential to formulate proteins into long-acting …
WebOn 7th March 2024, Midatech announced its intention to Consolidate its Ordinary shares, change its name and cancel the listing of its Ordinary shares on AIM. mixology hoursWeb10 jan. 2024 · Midatech announces EUR 1.5 million loan facility for manufacturing site - Basque Regional Government approves loan facility to support manufacturing facility in Bilbao - Funds to be used as part of commercial scale up for MTD201 and Q-Sphera ™ platform Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the R&D company focused on … mixology hackingWeb21 mei 2024 · Midatech commences equivalence study in exploratory phase of Q-Octreotide (MTD201) for carcinoid cancer and acromegaly - Initial dosing administered in potentially pivotal phase for core near-to-market oncology asset Midatech (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on … inground pool safety cover sale